[1] M. OBUKOWICZ. Novel, selective Δ6 or Δ5 fatty acid desaturase inhibitors as antiinflammatory agents in mice[J]. Lipids, 1999, 34 S1Part2: S149. DOI:
10.1007/bf02562269[2] SHAWN D. HARMON. Effect of the Δ6-desaturase inhibitor SC-26196 on PUFA metabolism in human cellsinhibitor SC-26196 on PUFA metabolism in human cells[J]. Lipids, 2003, 38 4: 469-476. DOI:
10.1007/s11745-003-1086-9[3] CHRISTOPHER M MULLIGAN. Inhibition of delta-6 desaturase reverses cardiolipin remodeling and prevents contractile dysfunction in the aged mouse heart without altering mitochondrial respiratory function.[J]. Journals of Gerontology Series A-Biological Sciences and Medical Sciences, 2014, 69 7: 799-809. DOI:
10.1093/gerona/glt209[4] T. LAVAL. De novo synthesized polyunsaturated fatty acids operate as both host immunomodulators and nutrients for Mycobacterium tuberculosis[J]. eLife, 2021. DOI:
10.1101/2021.07.08.451715